RESUMO
An infectious molecular clone of human immunodeficiency virus type 1 (HIV-1), designated pNLaiKH, which is tropic for both lymphocytic and monocytic cells, was constructed. To study the early function of HIV-1 Gag proteins in two types of cells, the mutations known to give host cell-dependent early defects were introduced into pNLaiKH, and the replication potentials and defective replication sites in the cells of the resultant mutants were monitored. All mutants grew in some lymphocytic cells, but not at all in monocytic cells. A nucleocapsid mutant was found to be defective at an early replication phase in all the cell lines to various extent, as expected. In contrast, a matrix mutant and a capsid mutant displayed a replication defect in a producer-cell-dependent manner. These results demonstrated that complex interactions of cell factors and Gag proteins are involved in an early process of HIV-1 replication.
Assuntos
Produtos do Gene gag/metabolismo , HIV-1/fisiologia , Linfócitos/virologia , Replicação Viral , Linhagem Celular , Cloranfenicol O-Acetiltransferase/metabolismo , Produtos do Gene gag/genética , HIV-1/genética , Humanos , Monócitos/virologia , Mutação , Nucleocapsídeo/genética , DNA Polimerase Dirigida por RNA/metabolismo , Células U937RESUMO
There are several major strategies against HIV/AIDS. Of these, the gene therapy is a novel, challenging, and promising one. The target genes, which have been extensively studied for the potential gene therapy of HIV/AIDS, include those of cellular and viral origins. Especially, trans-dominant negative Tat, Rev, Env, Pol, and Gag mutants of HIV have currently attracted considerable attention. In this brief review, we summarize the nature of the HIV/SIV mutants of this category and discuss their future use for gene therapy with special reference to the dominant negative Gag mutants of HIV-1.
Assuntos
Genes gag , HIV-1/fisiologia , Mutação , Vírus da Imunodeficiência Símia/fisiologia , Replicação Viral/genética , Genes Dominantes , Terapia Genética , Infecções por HIV/terapia , HIV-1/genética , Humanos , Vírus da Imunodeficiência Símia/genéticaRESUMO
It has been well established that the Vif protein of human immunodeficiency virus type 1 (HIV-1) acts late in the viral life cycle and increases the infectivity of the progeny virions in a producer cell-dependent manner. The virions produced in the absence of Vif in non-permissive cells (Delta Vif) are defective for a step(s) before and/or during reverse transcription. In this review, the functional and structural analyses of these virions including our new data are summarized.
Assuntos
Produtos do Gene vif/fisiologia , HIV-1/fisiologia , Replicação Viral/fisiologia , Produtos do Gene vif/genética , Genes vif , HIV-1/genética , Humanos , Modelos Biológicos , Mutação , Replicação Viral/genética , Produtos do Gene vif do Vírus da Imunodeficiência HumanaRESUMO
Representative human and simian immunodeficiency viruses (HIV/SIVs) have been monitored for their Vif and Vpu activities in a wide variety of cells. In contrast to the prototype HIV-1, viruses of the other groups do not necessarily have these activities. Only HIV-2 and SIVmnd were clearly demonstrated to show the Vif and Vpu activities, respectively. The exchangeability of these accessory activities between viruses was then assessed to determine the relatedness of the viruses. Quite different from the results for Tat and Rev trans-activators, the activities are almost fully compatible between viruses. These results may facilitate the functional grouping of various HIV/SIVs.
Assuntos
Produtos do Gene vif/fisiologia , HIV/fisiologia , Vírus da Imunodeficiência Símia/fisiologia , Proteínas Virais Reguladoras e Acessórias/fisiologia , HIV-1/fisiologia , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Replicação Viral , Produtos do Gene vif do Vírus da Imunodeficiência HumanaRESUMO
We have previously shown that some gag gene mutants of human immunodeficiency virus type 1 (HIV-1) display a replication-defect in a cell-dependent manner. We and others have also demonstrated that the requirement of vif and vpu genes for HIV-1 replication is cell-dependent. To determine whether the cell-dependent growth of the HIV-1 gag mutants is related to the functions of Vif and Vpu, double mutants of gag-vif and gag-vpu were constructed, and monitored for their replication in various cell lines. The results obtained showed that the mutations in gag do not affect the cell-dependent functions of Vif and Vpu.
Assuntos
Proteínas do Capsídeo , Produtos do Gene gag/genética , Produtos do Gene vif/genética , HIV-1/genética , Proteínas Virais , Proteínas Virais Reguladoras e Acessórias/genética , Replicação Viral/genética , Capsídeo/genética , Linhagem Celular , Produtos do Gene vif/fisiologia , Antígenos HIV/genética , Proteína do Núcleo p24 do HIV/genética , HIV-1/patogenicidade , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Mutação , Proteínas Recombinantes de Fusão/genética , Células Tumorais Cultivadas/virologia , Proteínas Virais Reguladoras e Acessórias/fisiologia , Replicação Viral/fisiologia , Produtos do Gene gag do Vírus da Imunodeficiência Humana , Produtos do Gene vif do Vírus da Imunodeficiência HumanaRESUMO
Numerous lentiviruses, including human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) of causative agents of human AIDS as representative, have been recently isolated from various species of primates. The fundamental and most prominent feature of the viruses is the presence of a number of accessory genes in their genomes. Extensive biological and biochemical studies have demonstrated that the accessory gene products are not essential for viral replication at least in certain types of cells. Quite surprisingly, some of these accessory proteins are absolutely non-essential in any types of cells so far examined. In this brief review, our systematic genetic studies on the importance of the accessory proteins of HIV-1 and HIV-2 for viral replication are described and discussed.
Assuntos
HIV-1/fisiologia , HIV-2/fisiologia , Proteínas Virais Reguladoras e Acessórias/fisiologia , Animais , Genoma Viral , HIV-1/genética , HIV-2/genética , Humanos , Mutação , Proteínas Virais Reguladoras e Acessórias/genética , Replicação ViralRESUMO
Various gag mutants of human immunodeficiency virus type 1 (HIV-1) generated in vitro were evaluated for their potentials to suppress the replication of wild-type (wt) virus. A single-round of wt virus replication in the presence of various mutant proteins was quantitatively monitored by transfection and infection experiments. Out of 38 mutants examined, 15 were demonstrated to interfere with the replication of wt HIV-1 at early and/or late viral replication phase. Some of these mutants were also effective against the replication of wt HIV-2. In this review, we focus on the mutants, which are able to act against a wide variety of HIV, and are very useful for future gene therapy against AIDS.
Assuntos
HIV-1/genética , HIV-1/fisiologia , Humanos , Mutação , Replicação ViralRESUMO
The tropism of human and simian immunodeficiency viruses (HIV and SIV) determined by sequences other than env has been studied. The restriction of HIV-1 replication in monkey cells was demonstrated to be regulated by viral non-env sequence. Likewise, the gag-pol region of SIVagm (virus of the African green monkey) genome was found to be responsible for growth restriction in human cells of the virus. No viral DNA synthesis was detected in cells nonpermissive for the viruses. In addition, a number of HIV-1 gag gene mutants, which have an early defect in viral replication cycle and direct no viral DNA synthesis in some cells, exhibited a phenotype of host range mutant. Taken together, it can be concluded that the viral tropism associated with the uncoating/ reverse transcription process does exist in HIV/SIV replication. Furthermore, many of the accessory gene mutants of HIV/SIV exhibit host cell-dependent replication property. In this review, we summarize these examples of non-env tropism of HIV/SIV.
Assuntos
Genes env , HIV-1/metabolismo , Vírus da Imunodeficiência Símia/metabolismo , Tropismo , Animais , Chlorocebus aethiops , Genes gag , Infecções por HIV/genética , Infecções por HIV/metabolismo , HIV-1/genética , Humanos , Vírus da Imunodeficiência Símia/genética , Proteínas Virais Reguladoras e Acessórias , Replicação Viral , Produtos do Gene vif do Vírus da Imunodeficiência HumanaRESUMO
Mutations were introduced into a genomic region encoding the C-terminal portion of Gag capsid protein of pathogenic simian immunodeficiency virus (SIVmac239). All the mutants generated were defective for virion production and were non-infectious for monkey cells. They all efficiently suppressed the replication of wild type SIVmac in monkey cells. These results were in good agreement with those obtained for human immunodeficiency virus type 1, showing the importance of SIV/monkey model system for studies on Gag.
Assuntos
Capsídeo/genética , Vírus da Imunodeficiência Símia/genética , Replicação Viral , Animais , Linhagem Celular Transformada , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , DNA Viral/genética , Vírus Defeituosos/genética , Células Eucarióticas/citologia , Células Eucarióticas/metabolismo , Células Eucarióticas/virologia , Células HeLa , Humanos , Macaca mulatta , Mutagênese Sítio-Dirigida , Mutação , DNA Polimerase Dirigida por RNA/metabolismoRESUMO
The growth kinetics of wild-type and nef mutant viruses of human immunodeficiency virus type 1 were comparatively analysed in several human CD4+ cell lines. Delayed replication of nef mutant virus was observed in all cell lines examined. To determine the stage in the virus replication cycle that is affected by Nef, a single-round replication assay was performed. Initially, the expression of marker genes in transfected cells was examined in order to study the role of Nef in the late phase of infection. The results obtained indicated that Nef is dispensable during the transcription to virion production stage. Next, the effect of Nef on the early phase was investigated with a single-round infection. It was demonstrated that Nef is required in the early phase of the virus replication cycle, from virion adsorption to integration. Finally, the infectivity of virus stocks prepared from four cell lines was determined. The relative infectivity of the nef mutant from the four cell lines differed. Taken together, we conclude that Nef acts via modulation of viral particles to enhance virus infectivity in a cell-dependent manner.
Assuntos
Produtos do Gene nef/fisiologia , HIV-1/patogenicidade , Humanos , Células Tumorais Cultivadas , Vírion/patogenicidade , Replicação Viral , Produtos do Gene nef do Vírus da Imunodeficiência HumanaRESUMO
A proviral nef gene mutant of human immunodeficiency virus type 1 (HIV-1) was evaluated for its defective early replication step. Virus stocks were prepared from six CD4-positive and -negative cell lines transfected with wild-type (wt) or the nef mutant clone and inoculated into two target CD4-positive cell lines to monitor the efficiency of viral entry process. The nef mutant virions produced in one cell line exhibited a severe defect in the entry process, although those produced in the other five cell lines were only slightly less efficient than the wt virions at entering into cells. These results have demonstrated that the HIV-1 Nef is critical for efficient viral entry in a producer cell-dependent manner.
Assuntos
Linfócitos T CD4-Positivos/virologia , Produtos do Gene nef/fisiologia , Infecções por HIV/virologia , HIV-1/fisiologia , Replicação Viral/fisiologia , Linfócitos T CD4-Positivos/fisiologia , Linhagem Celular , Humanos , Produtos do Gene nef do Vírus da Imunodeficiência HumanaRESUMO
Various gag gene mutants of human immunodeficiency virus type 1 (HIV-1) were monitored for their replication potentials and defective replication sites in various CD4-positive T-cell lines. Some matrix, capsid, and nucleocapsid mutants displayed a replication defect in a cell-dependent manner. The single-round replication assays demonstrated that these mutants were defective at an early infection phase also in a cell-dependent way. These results indicated that interaction of a cell factor(s) and Gag proteins is involved in an early process of HIV-1 replication.
Assuntos
Produtos do Gene gag/metabolismo , Genes gag , HIV-1/fisiologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/virologia , Linhagem Celular , Cloranfenicol O-Acetiltransferase/biossíntese , Transcriptase Reversa do HIV/biossíntese , HIV-1/genética , Humanos , Cinética , Proteínas Recombinantes/biossíntese , Transfecção , Replicação ViralRESUMO
Gag gene mutants of human immunodeficiency virus type 1 (HIV-1) were analyzed for their potentials of inhibiting the replication of wild-type (wt) HIV-2, the second AIDS virus, in a single-round of viral replication. Of twenty-two HIV-1 gag mutants examined, seven were found to efficiently interfere with the replication of wt HIV-2. Some mutants, which can suppress the replication of wt HIV-1, did not show this inhibitory effect. These mutants were defective at the late phase of viral replication. A mutant designated NL-C1a was demonstrated to be very effective against the replication of HIV-1 and HIV-2 in monocytic cells as well as in lymphocytic cells.
Assuntos
Produtos do Gene gag/genética , HIV-1/genética , HIV-2/genética , Supressão Genética/genética , Linfócitos T CD4-Positivos/virologia , Produtos do Gene gag/farmacologia , Genes Reporter/genética , Genes gag/genética , Terapia Genética , Proteína do Núcleo p24 do HIV/genética , Proteína do Núcleo p24 do HIV/farmacologia , Humanos , Monócitos/virologia , Mutação/genética , Proteínas Virais/genética , Proteínas Virais/farmacologiaRESUMO
Simian immunodeficiency virus isolated from African green monkeys (SIVagm) does not grow in many of human cell lines such as CEM x 174, H9, and MT-4, but could replicate in some human cell lines. Sequence of SIVagm responsible for its narrow host range was determined by making and monitoring growth potential of chimeric clones between SIVagm and human immunodeficiency virus type 1 (HIV-1). The results obtained indicated that the gag-pol region determines the observed narrow host range. By monitoring virus DNA synthesis and progeny virion production, the defect(s) of SIVagm in the replication in the restricted cells was demonstrated to be located at early phase.
Assuntos
Genes gag , Genes pol , Vírus da Imunodeficiência Símia/genética , Vírus da Imunodeficiência Símia/fisiologia , Animais , Chlorocebus aethiops , DNA Viral/biossíntese , HIV-1/genética , HIV-1/fisiologia , Humanos , Tropismo , Células Tumorais CultivadasRESUMO
We have previously demonstrated that many of gag mutants of human immunodeficiency virus type 1 (HIV-1) inhibited the replication of wild-type (wt) HIV-1. In this study, various HIV-1 mutants were systematically analyzed with respect to their ability to suppress the replication of wt HIV-1. Sixteen mutants of all eight HIV-1 genes other than gag were evaluated for their inhibitory effects. Only an env mutant designated NL-Hi efficiently interfered with the replication of wt HIV-1 in a single round of infection. The NL-Hi did not affect the late replication processes of wt virus, including transcription, translation, and assembly/release. Virions produced in the presence of the mutant Env were defective for the viral entry process in the early phase of HIV-1 replication cycle.
Assuntos
HIV-1/genética , HIV-1/fisiologia , Mutação , Replicação Viral/genética , Linhagem Celular , Expressão Gênica , Genes Virais , Genes env , Genes gag , Humanos , Fenótipo , Interferência Viral/genéticaRESUMO
Two distinct infectious molecular clones of human immunodeficiency type 2 (HIV-2) were analyzed for their biological properties in six cell lines. Fourteen chimeric and ten mutant viruses were constructed from these two viral genomes to localize the genetic determinants responsible for the phenotypes. Growth property of the viruses in the cell lines, together with the biochemical data, showed that a major determinant for the viral tropism resides in the env gene. In addition, in some cell lines, the accessory genes vif and nef affected the efficiency of virus replication. Thus, like HIV-1, mutations in the auxiliary and env genes of HIV-2 contributed much to the differences in virological characteristics.
Assuntos
Mapeamento Cromossômico , HIV-2/genética , HIV-2/fisiologia , Replicação Viral/genética , Sequência de Bases , Linhagem Celular Transformada , DNA Viral , Produtos do Gene tat/metabolismo , Células HL-60 , Humanos , Dados de Sequência Molecular , Recombinação Genética , Células Tumorais Cultivadas , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
A mutant of human immunodeficiency virus type 1 (HIV-1), which is deficient for Gag precursor cleavage and noninfectious, was characterized with respect to its defective step in the viral replication phase. Upon transfection, the mutant produced a normal level of progeny virions as monitored by electron microscopy and RNA hybridization. Single-round replication assay demonstrated, in contrast, that the mutant was defective at the early phase of the replication cycle. Furthermore, no viral DNA was detected in the cells infected with the mutant. Taken together, it is concluded that maturation of Gag precursor protein of HIV-1 is required for an early event(s) before or during a coupled process of uncoating/reverse transcription.
Assuntos
Produtos do Gene gag/metabolismo , HIV-1/fisiologia , Precursores de Proteínas/metabolismo , Replicação Viral , Southern Blotting , Western Blotting , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , DNA Viral , Produtos do Gene gag/genética , Protease de HIV/genética , Protease de HIV/metabolismo , HIV-1/genética , HIV-1/ultraestrutura , Humanos , Microscopia Eletrônica , Mutação , Fenótipo , Reação em Cadeia da Polimerase , Precursores de Proteínas/genética , RNA Viral/análise , RNA Viral/genética , Transfecção , Células Tumorais CultivadasRESUMO
In-frame mutations were introduced into various portions of the human immunodeficiency virus type 1 (HIV-1) gag gene, and potentials of the mutants to suppress the replication of wild-type HIV-1 were monitored. In contrast to results obtained with matrix and nucleocapsid mutants, almost all capsid mutants blocked HIV-1 replication completely in single-round replication assays. A capsid mutant designated C6b was demonstrated to be one of the most efficient inhibitors for HIV-1 reported to date, and to be effective at both early and late viral replication phases. T-cells, which are engineered to express the C6b Gag in response to HIV-1 infection, were perfectly resistant to HIV-1.
Assuntos
Capsídeo/genética , Produtos do Gene gag/fisiologia , Genes gag , HIV-1/genética , HIV-1/fisiologia , Replicação Viral , Western Blotting , Linfócitos T CD4-Positivos/virologia , Capsídeo/química , Capsídeo/fisiologia , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Expressão Gênica , Produtos do Gene gag/genética , Vetores Genéticos , Humanos , Mutagênese , Mutação , Transfecção , Células Tumorais CultivadasRESUMO
A series of human immunodeficiency virus type 1 (HIV-1) proviral gag gene mutants carrying bacterial CAT gene were constructed and monitored for the expression of reverse transcriptase and CAT in a highly sensitive single-round replication assay system to determine the defective replication phase in lymphocytic cells. All the mutants displayed no abnormality in the process of transcription and translation at late replication stage. In contrast, some matrix, capsid, and p6 mutants were defective at final phase, that is, assembly and virion release. Most of the mutants including nucleocapsid mutants, which showed normal phenotype at late stage, were defective at early replication phase. From the functional domain map thus obtained, it is evident that HIV-1 Gag proteins are required for both early and late replication phases.